In the current study, we evaluated the clinical features, genetic characteristics, and prognostic significance of 246 cases of DLBCL with MYC or BCL2 CNA, rearrangement and protein expression. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.